Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organigram Global Inc. - Common Shares (NQ:OGI)

1.425 -0.055 (-3.72%)
Streaming Delayed Price Updated: 3:55 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Organigram Global Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
From Organigram Holdings Inc.
Via Business Wire
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
From Organigram Holdings Inc.
Via Business Wire
Organigram Successfully Closes Previously Announced Underwritten Public Offering
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Pricing of Overnight Marketed Public Offering
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Launch of Overnight Marketed Public Offering
From Organigram Holdings Inc.
Via Business Wire
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
From Organigram Holdings Inc.
Via Business Wire
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports First Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Completes First Shipment to Germany, Extending its International Reach
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces the First Tranche Closing from BAT Investment
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Appointment of Karina Gehring to Board of Directors
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT
From Organigram Holdings Inc..
Via Business Wire
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports Fiscal 2023 Results1
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023
From Organigram Holdings Inc.
Via Business Wire
Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash
From Organigram Holdings Inc.
Via Business Wire
Organigram Increases Investment in Phylos After Successful Milestone Achievement
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Interim Chief Financial Officer
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
From Organigram Holdings Inc.
Via Business Wire
Organigram Provides Corporate Update
From Organigram Holdings Inc.
Via Business Wire
Organigram Holdings Inc. Files Final Base Shelf Prospectus
From Organigram Holdings Inc.
Via Business Wire
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Resignation of Board Member
From Organigram Holdings Inc.
Via Business Wire
Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower
From Organigram Holdings Inc.
Via Business Wire
Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer
From Organigram Holdings Inc.
Via Business Wire
Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS
From Organigram Holdings Inc.
Via Business Wire
Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted
From Organigram Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.